Project Details
Description
A Phase 4, Randomized, Double-Blind, Active And Placebo -Controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatri
Status | Finished |
---|---|
Effective start/end date | 11/1/11 → 10/31/15 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.